|
|
|||||||||||
Kingshill Research Centre, Victoria Hospital, Okus Road, Swindon SN1 4HZ
The pharmaceutical companies Janssen-Cilag and Shire met the cost of the administration of this project.
AIMS AND METHOD
The National Institute for Clinical Excellence (NICE) has issued guidance regarding the treatment of Alzheimer's disease. A postal survey of old age psychiatrists, geriatricians and neurologists was conducted to establish working practice pre-NICE and investigate expectations about the effect of this guidance.
RESULTS
The overall response rate was 26.3%. Old age psychiatrists prescribe the majority of drugs for the treatment of Alzheimer's disease. There was variation in the annual expenditure on such treatment. The main reason for non-prescription was a lack of funding. Over 80% of doctors thought that patients with mild disease should now be targeted for treatment.
CLINICAL IMPLICATIONS
In order to implement the guidance it will be necessary to address the issue of funding and have clear role allocation between local services.
This article has been cited by other articles:
![]() |
J. Cerejeira and E. B. Mukaetova-Ladinska Treating dementia: will the NICE guidance 2006 change our clinical practice? Age Ageing, November 1, 2007; 36(6): 605 - 606. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| British Journal of Psychiatry | Advances in Psychiatric Treatment | All RCPsych Journals |